FDA-Approved Tyrosine Kinase Inhibitors
收藏数据链接：
官方服务：
资源简介：
We analyzed descriptive data for indications and usage, type of approval, approval dosage, dose reduction recommendation, median age, race, dose reduction rates, drug discontinuation rates, dose modification, warnings, adverse reactions, clinical trial experience, and geriatric use above 65 years and 75 years.
提供机构：
Reddy, Neha创建时间：
2023-01-02
